Calvin L. Day
About
In The Last Decade
Calvin L. Day
36 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Epidemiology 2.1k
- Oncology 2.1k
- Dermatology 1.6k
- Molecular Biology 657
- Surgery 403
Countries citing papers authored by Calvin L. Day
This map shows the geographic impact of Calvin L. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin L. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin L. Day more than expected).
Fields of papers citing papers by Calvin L. Day
This network shows the impact of papers produced by Calvin L. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin L. Day. The network helps show where Calvin L. Day may publish in the future.
Co-authorship network of co-authors of Calvin L. Day
This figure shows the co-authorship network connecting the top 25 collaborators of Calvin L. Day. A scholar is included among the top collaborators of Calvin L. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin L. Day. Calvin L. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip breakdown → | 1059 |
| 3 | Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐Up breakdown → | 535 |
| 4 | 324 | |
| 5 | 23 | |
| 6 | 13 | |
| 7 | 11 | |
| 8 | 5 | |
| 9 | Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death. | 3 |
| 10 | 19 | |
| 11 | 1 | |
| 12 | 20 | |
| 13 | 150 | |
| 14 | 5 | |
| 15 | Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. | 19 |
| 16 | 21 | |
| 17 | 11 | |
| 18 | 91 | |
| 19 | 61 | |
| 20 | 106 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.